Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 5, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

February 19, 2019

Conditions
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Interventions
BIOLOGICAL

Dalantercept

Given SC

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (40)

10065

Memorial Sloan Kettering Cancer Center, New York

19001

Jefferson Abington Hospital, Abington

19107

Thomas Jefferson University Hospital, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

19718

Christiana Care Health System-Christiana Hospital, Newark

19958

Beebe Medical Center, Lewes

21921

Christiana Care - Union Hospital, Elkton

31405

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah

39216

University of Mississippi Medical Center, Jackson

44060

UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor

44106

Case Western Reserve University, Cleveland

44111

Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland

44124

Hillcrest Hospital Cancer Center, Mayfield Heights

44195

Cleveland Clinic Foundation, Cleveland

49007

West Michigan Cancer Center, Kalamazoo

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

54143

Bay Area Medical Center, Marinette

54221

Holy Family Memorial Hospital, Manitowoc

54301

Saint Vincent Hospital Cancer Center Green Bay, Green Bay

54303

Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay

57104

Sanford Cancer Center Oncology Clinic, Sioux Falls

Sanford NCI Community Oncology Research Program of the North Central Plains, Sioux Falls

62526

Decatur Memorial Hospital, Decatur

63110

Washington University School of Medicine, St Louis

68114

Nebraska Methodist Hospital, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

79106

The Don and Sybil Harrington Cancer Center, Amarillo

80524

Poudre Valley Hospital, Fort Collins

87102

University of New Mexico Cancer Center, Albuquerque

98104

Pacific Gynecology Specialists, Seattle

98109

Seattle Cancer Care Alliance, Seattle

98133

University of Washington Medical Center - Northwest, Seattle

98195

University of Washington Medical Center - Montlake, Seattle

06102

Hartford Hospital, Hartford

06050

The Hospital of Central Connecticut, New Britain

04102

Maine Medical Center-Bramhall Campus, Portland

01605

UMass Memorial Medical Center - Memorial Division, Worcester

02905

Women and Infants Hospital, Providence

57117-5134

Sanford USD Medical Center - Sioux Falls, Sioux Falls

54301-3526

Green Bay Oncology at Saint Vincent Hospital, Green Bay

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT01720173 - Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | Biotech Hunter | Biotech Hunter